期刊
AUTOIMMUNITY REVIEWS
卷 22, 期 5, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.autrev.2023.103287
关键词
Autoimmunity; autoinflammatory syndrome; induced by adjuvants; ASIA; Silicone breast implants; Explantation; Fibromyalgia; Chronic fatigue syndrome; myalgic; encephalomyelitis; COVID-19 vaccination; Autonomic nervous system; Small fiber neuropathy; HPV vaccine
类别
ASIA syndrome, first described in 2011, is an autoimmune/inflammatory syndrome induced by adjuvants. It aims to uncover the common pathway of autoimmune pathogenesis caused by certain immune stimulatory environmental factors such as aluminum salts, medical implants, and infectious agents.
In 2011, a syndrome entitled ASIA (Autoimmune/inflammatory Syndrome Induced by Adjuvants; Shoenfeld's syndrome) was first described. ASIA aimed to organize under a single umbrella, the existing evidence regarding certain environmental factors which possess immune stimulatory properties, in order to shed light on a common pathway of autoimmune pathogenesis. Such environmental immune stimulators, or adjuvants, include among others: aluminum salts as in vaccines, various medical implants, as well as various infectious agents. After the launch of the ASIA syndrome, the expansion and recognition of this syndrome by different researchers from different countries began. During the past decades, evidence had been accumulating that (auto)immune symptoms can be triggered by exposure to environmental immune stimulatory factors that act as an adjuvant in genetically susceptible individuals. A panoply of unexplained subjective and autonomic-related symptoms has been reported in patients with ASIA syndrome. The current review summarizes and updates accumulated knowledge from the past decades, describing new adjuvants- (e.g. polypropylene meshes) and vaccine- (e.g. HPV and COVID vaccines) induced ASIA. Furthermore, a direct association between inflammatory/autoimmune diseases with ASIA syndrome, will be discussed. Recent cases will strengthen some of the criteria depicted in ASIA syndrome such as clear improvement of symptoms by the removal of adjuvants (e.g. silicone breast implants) from the body of patients. Finally, we will introduce additional factors to be included in the criteria for ASIA syndrome such as: (1) dysregulated non-classical autoantibodies directed against G-protein coupled receptors (GPCRs) of the autonomic nervous system and (2)) small fiber neuropathy (SFN), both of which might explain, at least in part, the development of 'dysautonomia' reported in many ASIA patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据